Orthocell secures Brazilian approval for Striate+ as global...
Orthocell Ltd has continued its global expansion for its dental guided bone regeneration membrane, Striate+™, paving the way for entry into the A$100 million (US$65 million) Brazilian market. The company has received regulatory approval from the Brazilian …